- Home
- FDMT vs LGI Comparison
FDMT vs LGI Comparison
Compare FDMT & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- LGI
- Stock Information
- Founded
- FDMT 2013
- LGI 2004
- Country
- FDMT United States
- LGI United States
- Employees
- FDMT N/A
- LGI N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- LGI
- Sector
- FDMT Health Care
- LGI
- Exchange
- FDMT Nasdaq
- LGI Nasdaq
- Market Cap
- FDMT 192.2M
- LGI 210.5M
- IPO Year
- FDMT 2020
- LGI N/A
- Fundamental
- Price
- FDMT $4.38
- LGI $16.68
- Analyst Decision
- FDMT Buy
- LGI
- Analyst Count
- FDMT 10
- LGI 0
- Target Price
- FDMT $32.33
- LGI N/A
- AVG Volume (30 Days)
- FDMT 410.7K
- LGI 41.1K
- Earning Date
- FDMT 08-07-2025
- LGI 01-01-0001
- Dividend Yield
- FDMT N/A
- LGI 7.10%
- EPS Growth
- FDMT N/A
- LGI N/A
- EPS
- FDMT N/A
- LGI N/A
- Revenue
- FDMT $23,000.00
- LGI N/A
- Revenue This Year
- FDMT $13,048.65
- LGI N/A
- Revenue Next Year
- FDMT N/A
- LGI N/A
- P/E Ratio
- FDMT N/A
- LGI N/A
- Revenue Growth
- FDMT N/A
- LGI N/A
- 52 Week Low
- FDMT $2.24
- LGI $12.66
- 52 Week High
- FDMT $28.93
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- FDMT 56.61
- LGI 54.22
- Support Level
- FDMT $4.23
- LGI $16.77
- Resistance Level
- FDMT $4.50
- LGI $17.03
- Average True Range (ATR)
- FDMT 0.26
- LGI 0.17
- MACD
- FDMT 0.01
- LGI -0.02
- Stochastic Oscillator
- FDMT 85.37
- LGI 56.18
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.